Accumulating evidence suggests that aberrant expressions of chemokines CCL regulate the recruitment of immune cells in tumors, such as CD8+ tumor infiltrating T cells and macrophages, which may ultimately affect the clinical outcome of cancer patients (Dangaj et al., 2019; Lee et al., 2017). The gene discussed is CD8A; the disease is cancer.